KNOLL CAPITAL MANAGEMENT, LP Information

5 EAST 44TH STREET, NEW YORK, New York, 10017, (212) 808-7474

Report Date: 06/30/2015

Position Statistics

Total Positions 19
New Positions 2
Increased Positions 4
Decreased Positions 1
Positions with Activity 5
Sold Out Positions 0
Total Mkt Value (in $ millions) 248

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 93.63%
Services
Technology
Transportation
Utilities

19 Positions as of 06/30/2015

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
MEDIVATION INC COM 193,637 New 2,198,919
AMPIO PHARMACEUTICALS INC COM 9,962 New 3,388,322
ALCOBRA LTD SHS 8,566 New 1,115,315
SYNTHETIC BIOLOGICS INC COM 8,502 New 3,400,816
ABEONA THERAPEUTICS INC COM 6,350 5,355 538.09 1,359,767
NEWLINK GENETICS CORP COM 4,600 New 102,437
ADVAXIS INC COM NEW 4,070 New 275,000
CORBUS PHARMACEUTICALS HLDGS COM 3,343 3,343 New 1,750,000
BIO BLAST PHARMA LTD SHS 1,975 New 338,110
CALADRIUS BIOSCIENCES INC COM 1,540 1,540 New 1,000,000
KERYX BIOPHARMACEUTICALS INC COM 1,236 New 200,000
ADVAXIS INC WT EXP 071518 1,143 New 112,500
ALDEYRA THERAPEUTICS INC COM 980 New 135,800
LION BIOTECHNOLOGIES INC COM 690 -21 (2.9) 97,100
OHR PHARMACEUTICAL INC COM NEW 584 New 205,000
GALMED PHARMACEUTICALS LTD SHS 583 New 65,000
EVOKE PHARMA INC COM 217 7 3.38 55,660
ZOSANO PHARMA CORP COM 162 New 20,000
APTOSE BIOSCIENCES INC COM NEW 108 New 20,000